P127
P1830
P355
The Mycophenolate Pregnancy RegistryA Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck)Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck)Cross Sectional Analysis of Healthcare for Psoriasis in 5 European CountriesAntiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
P767
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating FactorStudy to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting ConditionsTo Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed ConditionsComparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed ConditionsComparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting ConditionsA Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting ConditionsA Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting ConditionsBioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting ConditionsTo Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting ConditionsHX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational AgePhase III Study Comparing the Efficacy and Safety of EP2006 and FilgrastimGP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular LymphomaNon-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft RejectionReal-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s DiseaseGP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyMONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5Clinical Trial With Mesalamine 1g SuppositoriesA Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisNon-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell DonorsStudy to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer PatientsRandomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis PatientsStudy to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis PatientsStudy to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and HumiraPhase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin AlfaRemission of ICD by Switching Dopamine Agonist to Levodopa/CarbidopaPramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's DiseasePhase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimA Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisRelative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting ConditionsRelative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed ConditionsRelative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting ConditionsTo Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting ConditionsTo Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting ConditionsTo Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mgTo Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting ConditionsTo Demonstrate the Effect of Food on the Bioavailability of Glipizide
P859
description
Arzneimittelhersteller
@de
Pharmaceutical company
@en
شركة صيدلانية
@ar
name
Sandoz
@bg
Sandoz
@de
Sandoz
@en
Sandoz
@fr
Sandoz
@nb
Sandoz
@nl
Sandoz
@pt
Sandoz
@ro
Sandoz
@ru
Sandoz
@sv
type
label
Sandoz
@bg
Sandoz
@de
Sandoz
@en
Sandoz
@fr
Sandoz
@nb
Sandoz
@nl
Sandoz
@pt
Sandoz
@ro
Sandoz
@ru
Sandoz
@sv
altLabel
Chemiefirma Kern und Sandoz
@de
Chemiefirma Kern und Sandoz
@en
Kern and Sandoz Chemistry Firm
@en
Sandoz AG
@en
Sandoz Pharmaceuticals
@en
prefLabel
Sandoz
@bg
Sandoz
@de
Sandoz
@en
Sandoz
@fr
Sandoz
@nb
Sandoz
@nl
Sandoz
@pt
Sandoz
@ro
Sandoz
@ru
Sandoz
@sv